CVS Health (CVS) Stock Price & Analysis
Score
AI Analysis
SnapshotCVS Health reads as an income name — Stocklytics 50/100, with a 3.0% dividend yield in the thesis. Under the hood: P/E 10.2, about 30% below its own multi-year median, plus revenue compounding ~8% annually over recent years.
Price History
Price: —
Fair value: —
—
P/E (TTM): —
Net Income (TTM): —
Score: —
—
Score Breakdown
Market percentile scores loading…
Value
Growth
Quality
Financial Summary
CVS Health Corp. (CVS) last printed $89.35. Equity value is $114.32B. Trailing earnings multiple 10.34. The revenue row is reported history. Targets and ratings are on the forecast page.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| $177.55B | $184.79B | $194.58B | $256.78B | $268.71B | $292.11B | $322.47B | $357.78B | $372.81B | $402.07B |
About
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.